Vertex Pharmaceuticals Incorporated Share Price Today, Forecast Target, Chat & Where To Buy [VRTX]

  • Today's Vertex Pharmaceuticals Incorporated share price is 438.71 (as of 16:00 02-Apr-2026) which is a change of -8.55 or -1.91% from the last closing price of 438.71.
  • With 1,244,992 shares traded this gives Vertex Pharmaceuticals Incorporated a market capitalisation of 111,447,297,840.
  • Vertex Pharmaceuticals Incorporated's most recent daily high has been 449.62 and daily low 436.56. The Vertex Pharmaceuticals Incorporated share price 52 week high has been 510.77 and the 52 week low 362.5.
  • Based on the most recent Vertex Pharmaceuticals Incorporated share price opening of 438.71, the current Vertex Pharmaceuticals Incorporated EPS (earnings per share) are 15.32 and the PE (price earnings ratio) is 28.63.

Featured Brokers For Buying Vertex Pharmaceuticals Incorporated Shares

It currently costs 438.71 to buy one share in Vertex Pharmaceuticals Incorporated (as of 16:00 02-Apr-2026) which is a change of -8.55 or -1.91% from the last closing price of 447.26. To buy shares in Vertex Pharmaceuticals Incorporated you will need a stock trading platform like City Index.

We have ranked, compared and reviewed some of the best share-dealing platforms and accounts in the UK that are regulated by the Financial Conduct Authority (FCA). The main things to compare when choosing a share dealing account are the costs of buying and selling shares (trading fees) and how much it will cost to keep those shares on your account. You should also compare account types so you have the option to deal shares in a tax-efficient ISA, SIPP or for your children.

Is Vertex Pharmaceuticals Incorporated A Good Investment?

The below Vertex Pharmaceuticals Incorporated share price analysis and market data includes key financials, earnings estimates, peer performance, dividends, news and a company profile that will give you an indication as to whether this stock is a buy, sell or hold. Subscribe to Good Money Guide Analysis for expert opinion on the latest investment opportunities.

Tell us what you think:

Scroll to Top